CVS Health ( (CVS)) just unveiled an update. On April 7, 2025, CVS Health announced key leadership changes effective in May 2025. Brian O. Newman was appointed as the Executive Vice President and ...

CVS Health chopped its 2024 forecast for a third time and changed the leadership of its health insurance business where it continues to struggle with rising costs. CEO Karen Lynch will lead the ...

In connection with the leadership change, CVS issued preliminary guidance for Q3 indicating GAAP diluted earnings per share of $0.03-$0.08 and non-GAAP EPS of $1.05-$1.00, which fell short of $1. ...

No decision is imminent and it's possible there won't be changes to CVS' business ... "Glenview and CVS Leadership are engaged in good faith and constructive conversations through which Glenview ...

CVS Health has announced key leadership changes, appointing Brian Newman as CFO and Amy Compton-Phillips, MD, as executive vice president and chief medical officer. Here are five things to know: 1.

CVS Health has undergone significant executive changes with the appointment of Brian Newman as CFO and Amy Compton-Phillips as Chief Medical Officer. These leadership updates, coupled with a ...

"The new leadership announcement gives us hope that CVS is moving quickly to improve ... Having said that, we will be watching closely what changes management will make and how those changes ...

CVS Health CEO Karen Lynch has stepped down ... Leerink Partners analyst Michael Cherny said the leadership change was unexpected, though he understood the rationale behind it “following ...

"The new leadership announcement gives us hope that CVS is moving quickly to improve ... Having said that, we will be watching closely what changes management will make and how those changes ...

Dr. Creagh Milford will continue to be interim president of retail health at CVS Health until the company finds a replacement, a spokesperson said.

"Their collective and individual experience and expertise are well suited to CVS Health and we welcome them both to our leadership team.” Joyner continued, “I am personally grateful for the leadership ...

In connection with the leadership change, CVS issued preliminary guidance for Q3 indicating GAAP diluted earnings per share of $0.03-$0.08 and non-GAAP EPS of $1.05-$1.00, which fell short of $1. ...